vs
NEOGENOMICS INC（NEO）与LiveRamp Holdings, Inc.（RAMP）财务数据对比。点击上方公司名可切换其他公司
LiveRamp Holdings, Inc.的季度营收约是NEOGENOMICS INC的1.1倍（$212.2M vs $186.7M），LiveRamp Holdings, Inc.净利率更高（18.8% vs -57.9%，领先76.6%），NEOGENOMICS INC同比增速更快（11.1% vs 8.6%），过去两年LiveRamp Holdings, Inc.的营收复合增速更高（11.1% vs 6.5%）
新基因组公司（NeoGenomics）是美国一家经CLIA认证的临床实验室企业，提供药企服务与信息服务，专注于癌症基因诊断检测，旗下检测服务涵盖细胞遗传学、荧光原位杂交（FISH）、流式细胞术、免疫组化、解剖病理学及分子遗传学等多个领域，为肿瘤相关诊断提供专业支持。
LiveRamp Holdings, Inc.是一家美国SaaS企业，核心业务为提供数据连接平台，服务涵盖数据导入、线下数据线上迁移等能力，助力企业开展营销相关的数据应用，为品牌及营销从业者的数字化运营提供技术支撑。
NEO vs RAMP — 直观对比
营收规模更大
RAMP
是对方的1.1倍
$186.7M
营收增速更快
NEO
高出2.5%
8.6%
净利率更高
RAMP
高出76.6%
-57.9%
两年增速更快
RAMP
近两年复合增速
6.5%
损益表 — Q1 FY2026 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $186.7M | $212.2M |
| 净利润 | $-108.0M | $39.9M |
| 毛利率 | 43.3% | 71.9% |
| 营业利润率 | 46.9% | 18.6% |
| 净利率 | -57.9% | 18.8% |
| 营收同比 | 11.1% | 8.6% |
| 净利润同比 | 42.0% | 255.7% |
| 每股收益（稀释后） | $-0.13 | $0.62 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NEORAMP
| Q1 26 | $186.7M | — | ||
| Q4 25 | $190.2M | $212.2M | ||
| Q3 25 | $187.8M | $199.8M | ||
| Q2 25 | $181.3M | $194.8M | ||
| Q1 25 | $168.0M | $188.7M | ||
| Q4 24 | $172.0M | $195.4M | ||
| Q3 24 | $167.8M | $185.5M | ||
| Q2 24 | $164.5M | $176.0M |
净利润NEORAMP
| Q1 26 | $-108.0M | — | ||
| Q4 25 | — | $39.9M | ||
| Q3 25 | $-27.1M | $27.4M | ||
| Q2 25 | $-45.1M | $7.7M | ||
| Q1 25 | $-25.9M | $-6.3M | ||
| Q4 24 | — | $11.2M | ||
| Q3 24 | $-17.7M | $1.7M | ||
| Q2 24 | $-18.6M | $-7.5M |
毛利率NEORAMP
| Q1 26 | 43.3% | — | ||
| Q4 25 | 43.8% | 71.9% | ||
| Q3 25 | 42.8% | 70.2% | ||
| Q2 25 | 42.6% | 70.1% | ||
| Q1 25 | 43.6% | 69.3% | ||
| Q4 24 | 44.9% | 71.9% | ||
| Q3 24 | 44.6% | 72.4% | ||
| Q2 24 | 44.1% | 70.6% |
营业利润率NEORAMP
| Q1 26 | 46.9% | — | ||
| Q4 25 | -7.1% | 18.6% | ||
| Q3 25 | -14.4% | 10.7% | ||
| Q2 25 | -26.3% | 3.7% | ||
| Q1 25 | -16.6% | -6.1% | ||
| Q4 24 | -10.7% | 7.5% | ||
| Q3 24 | -12.6% | 4.0% | ||
| Q2 24 | -13.3% | -3.0% |
净利率NEORAMP
| Q1 26 | -57.9% | — | ||
| Q4 25 | — | 18.8% | ||
| Q3 25 | -14.4% | 13.7% | ||
| Q2 25 | -24.9% | 4.0% | ||
| Q1 25 | -15.4% | -3.3% | ||
| Q4 24 | — | 5.7% | ||
| Q3 24 | -10.5% | 0.9% | ||
| Q2 24 | -11.3% | -4.3% |
每股收益（稀释后）NEORAMP
| Q1 26 | $-0.13 | — | ||
| Q4 25 | — | $0.62 | ||
| Q3 25 | — | $0.42 | ||
| Q2 25 | — | $0.12 | ||
| Q1 25 | — | $-0.10 | ||
| Q4 24 | — | $0.17 | ||
| Q3 24 | — | $0.03 | ||
| Q2 24 | — | $-0.11 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $146.1M | $403.4M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $828.8M | $962.3M |
| 总资产 | $1.3B | $1.3B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资NEORAMP
| Q1 26 | $146.1M | — | ||
| Q4 25 | $159.6M | $403.4M | ||
| Q3 25 | $164.1M | $376.9M | ||
| Q2 25 | $154.7M | $371.1M | ||
| Q1 25 | $346.2M | $420.8M | ||
| Q4 24 | $367.0M | $384.3M | ||
| Q3 24 | $362.0M | $348.4M | ||
| Q2 24 | $355.1M | $342.7M |
总债务NEORAMP
| Q1 26 | — | — | ||
| Q4 25 | $341.9M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $541.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益NEORAMP
| Q1 26 | $828.8M | — | ||
| Q4 25 | $836.6M | $962.3M | ||
| Q3 25 | $838.3M | $943.8M | ||
| Q2 25 | $854.0M | $947.8M | ||
| Q1 25 | $888.3M | $948.9M | ||
| Q4 24 | $902.3M | $957.7M | ||
| Q3 24 | $908.2M | $932.1M | ||
| Q2 24 | $915.9M | $951.9M |
总资产NEORAMP
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.4B | $1.3B | ||
| Q3 25 | $1.4B | $1.2B | ||
| Q2 25 | $1.4B | $1.2B | ||
| Q1 25 | $1.6B | $1.3B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.6B | $1.2B | ||
| Q2 24 | $1.6B | $1.2B |
负债/权益比NEORAMP
| Q1 26 | — | — | ||
| Q4 25 | 0.41× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.60× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-8.1M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | 0.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NEORAMP
| Q1 26 | $-8.1M | — | ||
| Q4 25 | $1.3M | — | ||
| Q3 25 | $8.9M | $57.4M | ||
| Q2 25 | $20.3M | $-15.8M | ||
| Q1 25 | $-25.3M | — | ||
| Q4 24 | $9.8M | $45.1M | ||
| Q3 24 | $9.2M | $55.6M | ||
| Q2 24 | $13.9M | $-9.3M |
自由现金流NEORAMP
| Q1 26 | — | — | ||
| Q4 25 | $-6.5M | — | ||
| Q3 25 | $570.0K | $56.8M | ||
| Q2 25 | $14.0M | $-16.2M | ||
| Q1 25 | $-29.8M | — | ||
| Q4 24 | $-1.8M | $44.8M | ||
| Q3 24 | $-1.6M | $55.4M | ||
| Q2 24 | $814.0K | $-9.6M |
自由现金流率NEORAMP
| Q1 26 | — | — | ||
| Q4 25 | -3.4% | — | ||
| Q3 25 | 0.3% | 28.4% | ||
| Q2 25 | 7.7% | -8.3% | ||
| Q1 25 | -17.8% | — | ||
| Q4 24 | -1.0% | 22.9% | ||
| Q3 24 | -0.9% | 29.8% | ||
| Q2 24 | 0.5% | -5.4% |
资本支出强度NEORAMP
| Q1 26 | — | — | ||
| Q4 25 | 4.1% | 0.1% | ||
| Q3 25 | 4.4% | 0.3% | ||
| Q2 25 | 3.5% | 0.2% | ||
| Q1 25 | 2.7% | 0.2% | ||
| Q4 24 | 6.7% | 0.1% | ||
| Q3 24 | 6.4% | 0.1% | ||
| Q2 24 | 8.0% | 0.1% |
现金转化率NEORAMP
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 2.09× | ||
| Q2 25 | — | -2.04× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 4.02× | ||
| Q3 24 | — | 32.10× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
